Introduction
Birth rates of homozygous β-thalassemia in different parts of the world have reduced considerably. Some smaller countries have reported no newborns with the disease. This has been achieved by control programs involving screening population surveys for heterozygous β-thalassemia, antenatal diagnosis along with increasing awareness in the medical profession, and in the population by large-scale education and counseling.
Control programs in Sardinia have substantially reduced the birth of homozygous thalassemics from 1:250 to as low as 1:4000 births. [1] Estimates of newborns with homozygous β-thalassemia in India vary considerably from 6,000 to 7,500 per year and even more depending on the gene prevalence, population, and birth rate of the region. [2] These are added annually to the already existing homozygote population. A frequency of β-thalassemia trait (βTT) of 1-3% and an overall 3.3% is stated for India. [3] Based on this figure, an estimate of 7,500 expected homozygous births per year have been made. [4] There is, therefore, a considerable discrepancy between the two estimates.
So what is the true gene frequency? There are several reports of the incidence of βTT from different parts of the country, which vary from less than 1% to 17%. [5, 6] Most of the earlier studies are in small groups of hospital-based patients and/or population groups. It is also known that the incidence is higher in some population groups. [7] There is a stated lack of information about the true gene frequency in many parts of the world. [8] Prevalence data preferably require large-scale population surveys and should not be hospital-based. [8] It is essential to have a more accurate assessment of the gene frequency of βTT in the population for planning control programs for β-thalassemia in the country.
India is a vast country with considerable regional and ethnic heterogeneity. A study of every region is an impossible proposition due to lack of infrastructural facilities, expertise, and resources.
In view of this, the Indian Council of Medical Research
Advisory Committee on Hematology recommended the formation of a Task Force to obtain information on the prevalence of β-thalassemia and other hemoglobinopathies in different regions in the country (ICMR).
It was, therefore, decided to focus attention on three cities, with a large population and well-established laboratory facilities. Mumbai, Delhi, and Kolkata were selected because they represent three different zones of the country. The population studied included school children from these cities. At the same time, such a study design would generate data on regional and ethnic variation, if any.
The results obtained in 11,090 school children from two of the three regions are based on the findings of the ICMR Collaborative Study Report. [9] This is the largest published study to date on the frequency of βTT and other hemoglobinopathies in India to the best of our knowledge.
Materials and Methods
The three institutions collaborating in this multicentric study were:
1. University College of Medical Sciences, Delhi.
Institute of Immunohaematology (IIH) now National
Institute of Immunohaematology (NIIH), Indian
Council of Medical Research, Mumbai.
3. School of Tropical Medicine, Kolkata.
This study included 5408 children from 11 schools in Delhi, 5682 from 75 schools in Mumbai, and 957 school children from Kolkata. The study in Kolkata was restricted both in numbers and objectives, and the data could not be included for comparison. The study was restricted to secondary school children in the age group of 11 to 18 years. Schools were more or less randomly selected, but an attempt was made to include most of the local population from different areas in the cities. This included children from all sections of society from different castes and religious groups. After obtaining the necessary permission from the Education Departments, the respective school principals were approached. An informative write-up on thalassemia was sent to the parents and after getting their consent, blood collection was organized during school hours.
Children were also clinically examined by the medical officers of the respective teams.
Two to three milliliter blood was collected in EDTA for complete blood count (CBC) and analysis of hemoglobin variants. Parents and siblings of children found to have any hemoglobinopathy were called for investigation for
βTT and follow-up for counseling if required.
CBC was measured by the Erma PC 604 particle counter. Peripheral blood smears were examined after staining with Wright's stain. [10] Hemoglobin electrophoresis [10] was carried out on cellulose acetate using TEB buffer, pH 8.6. [10] HbA 2 was estimated following elution after electrophoresis on cellulose using acetate, TEB buffer, pH 8.9. [11] HbA 2 was estimated in all the school children and the cut-off for HbA 2 was >3.5%. Confirmation was carried out by investigating parents and/or siblings. Hemoglobin F was quantitated in children by Singer's alkali denaturation method [12] in Mumbai and by Betke's method [13] in Delhi.
Solubility and sickling test were done in all cases with hemoglobin bands in the HbD/HbS region.
[10]
Results
Total 11,090 school children were screened for TT Figure 1 .
The male-female ratio of children investigated was 1:1 at Mumbai and 1.4:1 at Delhi.
Prevalence of hemoglobinopathies Table 1 shows the prevalence of βTT and Table 2 
Prevalence of β-thalassemia trait
The overall frequency of βTT in the school children was 4.05% being 2.68% and 5.49% in school children in Mumbai and Delhi, respectively [ Table 1 ].
In Delhi, the prevalence was higher in children from schools in the North and West (5.8-9.2%) of the city as compared to school children from South Delhi (2.2%, 2.3%) [ Table 3 ]. In school children from Delhi, the incidence of βTT ranged from 2.2% to 9.2%. Majority of the children in schools in the North and West originated from Punjab. In a school from Central Delhi, in which the population was predominantly of Karnataka origin, the frequency was 6.4%. Table 4 shows the frequency of βTT in the school children in Delhi analyzed according to their state of origin. Majority of the children screened were from Punjab (40.4%) and Uttar Pradesh (25.02%). The frequency varied from 2.4% to 7.6% in children belonging to different states, being the highest (7.6%) among the children from Punjab.
In Mumbai, the frequency of βTT in different caste Prevalence of anemia in children with β-thalassemia trait there were no heterozygous β-thalassemics with Hb >14/dl. Table 7 shows the hematologic parameters in children with βTT. 
Prevalence of anemia in children without any hemoglobinopathy

Prevalence of hepatosplenomegaly in children with β-thalassemia trait
In Mumbai, 19.7% children with βTT had hepatomegaly and 2.0% had splenomegaly; only a few children (0.7%) in Delhi had an enlarged liver and spleen.
HbA 2 concentration
HbA 2 levels ranged from 3.8% to 7.5% and 3.5% to 7.5% in children from Mumbai and Delhi, respectively [ Table 9 ].
HbF concentration
Distribution of the HbF concentration in 152 school children with βTT from Mumbai and 284 from Delhi is shown in Table 10 . In Mumbai, HbF concentration varied from 0% to 2% and in Delhi from 0% to >5%.
Prevalence of high HbF
The hematological findings in school children with high HbF in Mumbai and Delhi are shown in Tables 11 and 12 .
Twelve children in Mumbai (0.2%) and 14 in Delhi (0.3%) had a raised HbF (>5%) with a normal HbA 2 . These cases could either be heterozygotes for dβ-thalassemia or hereditary persistence of fetal hemoglobin (HPFH).
The HbF levels in these cases in Mumbai varied from
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Discussion
The primary objective of this large multicentric study was to determine the frequency of β-thalassemia and other hemoglobinopathies in different regions in the country. The study was restricted to secondary school children as they were considered to be fairly representative of all sections of the population. Besides they also comprised a population group which could be easily accessible for investigations and counseling.
Significant regional differences were observed in the prevalence of anemia both in children with βTT and in those without any Hb variant. Prevalence of anemia was lesser in the North as compared to the Western part of the country [ Table 8 ].
In 1975, Sukumaran had observed that β-thalassemia is probably the commonest inherited hemoglobin disorder on the Indian subcontinent. [6] HbE was more frequent in the east. The collaborative study on thalassemia in the two regions carried out on 11,090 school children establishes that βTT is the most frequent hemoglobinopathy of clinical importance although it varies considerably in the two regions and in different communities/caste groups and regions. The incidence was higher in the North (Delhi) being 5.5% than in the West (Mumbai) being 2.7%. The overall frequency was 4.05%. The lower incidence in Mumbai is probably due to the greater heterogeneity of the population screened.
The frequency of βTT varied widely in Delhi varying from 2.2% to 9.2%. It was interesting to note the higher frequency of βTT in children from schools in the West and North of Delhi (5.8-9.2%) where the population is largely of Punjabi origin compared to children from the south (2.2%, 2.3%) of the city [ Table 3 ]. One school in Central
Delhi had a predominant population of school children of Karnataka origin in whom the incidence was 6.4%.
The population of Delhi is largely of Punjabi origin since the partition of India when large segments of population from Western Punjab (now Pakistan) migrated to Punjab, Delhi, and surrounding areas. Although the number of school children from Himachal Pradesh, Kashmir, Karnataka, Tamil Nadu, Bihar, and Sindh were small, the frequency was significant ranging from 4.8% to 6.5%.
The lowest prevalence of βTT was observed in school children from Rajasthan and Maharashtra. In Delhi, there was less heterogeneity in the population, although number of children in some groups was restricted for a meaningful comparison.
Unlike the prevalence rate which varied considerably in school children from Delhi, in Mumbai it was evenly distributed in the city proper (2.8%), Western suburbs (2.34%), and the Eastern suburbs (2.72%). There was no significant difference in the prevalence of βTT in different schools as majority of them catered to a similar although cosmopolitan and heterogeneous population.
Nevertheless, it was noted that hardly any caste, or religious group, or population group from any state was free from β-thalassemia. It is interesting to note, however, that of 35 Maharashtrians screened in Delhi, 1 (2.9%) was heterozygous for β-thalassemia.
In Mumbai, the prevalence of β-thalassemia carriers varied from 0% to 6.9% in different caste and/or religious groups. It was greater than 4% in the Bhatia (5.9%), Bohri (4%), Khatri (6.9%), Lohana (5.6%), Protestants (4.1%), and scheduled castes (5.1%) [ Table   5 ]. Although a similar attempt at grouping was made in Delhi, most school children and parents were unable to provide details regarding their caste group. In Delhi, the frequency varied from 0% to 6.9% in these groups. The largest group of 2146 classified as "others" because of unavailability of detailed caste had a frequency of 6.05%
and belonged largely to migrant Punjabi population. The lower incidence in some groups known to have higher incidence of βTT is likely to be due to the smaller numbers of school children screened in each group.
In the neighboring country of Pakistan, the frequency of β-thalassemia has been reported to be 5.6%, [14] which is similar to that observed in school children from Delhi with a largely Punjabi population.
The prevalence of anemia was higher in children with Mediterranean and western countries have achieved a significant change in the homozygote population since the last two decades. [15] Other countries which also have Thalassemia Control Programs include Canada, [16] Israel, [17] Turkey, [18] Thailand, [19] Lebanon, [20] West Bank and Gaza Strip, [21] Malaysia, [22] China, [23] Iran, [24] Egypt, [25] and Pakistan. [14] In India, some screening and few antenatal programs [26] [27] [28] [29] [30] [31] [32] are also effective. However, several more centers are required. In these programs, of the population. [1] The importance of screening programs lies in the fact that they also provide a platform for increased awareness and education regarding thalassemia in the screened population and the associated population group including parents, teachers, friends, siblings, and employees.
Screening may be voluntary or mandatory.
β-thalassaemia carriers in a family are now easily detected using well-calibrated automated hematology cell counters and automated dedicated HPLC systems.
However, the prevention program including early screening of pregnant women and spouse of thalassemic pregnant women for antenatal diagnosis and termination of a homozygote fetus has been slow in India due to several factors. These include late reporting of pregnancy and the lack of widespread facilities for screening and antenatal diagnosis. Screening of extended family in large centers is improving; [33] however, a large number of the extended families do not appear to comprehend the problem and some prefer not to be investigated.
Debates on whether screening high school/college students along with thalassemia awareness programs will succeed in India have continued. The question also remains whether high school children screened and counseled would be sensitive to the information regarding thalassemia and whether they would remember their thalassemia status at the time of marriage. A 20-yearold study in high school children in Montreal, Canada, [16] suggests that this is an effective strategy. Screening programs for high school students are currently being used and recommended. [34] Premarital screening in the Indian population is still considered controversial. In Iran [35] and Turkey, [18] premarital screening of couples has been successful. This large program was started when termination of pregnancy was not considered an option.
However, currently Iran has a thriving antenatal diagnostic program and births of homozygous thalassemics are considerably lower. [24] A highly successful campaign for the detection of beta-thalassaemia trait and prevention of the birth of β-thalassemia major babies in the isle of Menorca has resulted in the absence of the birth of even a single homozygote in the population. [36] A multipronged approach including screening of high school/college students, premarital screening, and of the extended family of thalassemics along with antenatal diagnosis needs to be considered for this vast and ethnically diverse country. Education and awareness regarding thalassemics need to be accelerated urgently among medical practitioners, paramedics, the thalassemic and general population to reduce the morbidity and mortality and the financial and sociopsychological burden of the thalassemic families.
It has been estimated that the lifetime cost of healthcare, premature mortality, and lost earnings versus a national screening program including antenatal diagnosis in Israel [17] gives a cost-benefit ratio of 4.22:1 and adding a societal perspective 6.01:1. A recent report from Hong Kong [37] offers an almost similar cost-benefit ratio.
This study provides evidence that the birth rate of thalassemic homozygotes may be much higher than that stated in recent references. [4] Homozygote births are likely to be far higher in population groups with higher gene frequency. It is worthwhile carrying out screening programs, increasing awareness of the disease by education of the medical fraternity, the public, and particularly the β-thalassemia families to reduce the thalassemic homozygous population.
